NeuroOne Medical Technologies
NMTC
32 hedge funds and large institutions have $9.14M invested in NeuroOne Medical Technologies in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 11 closing their positions.
0.23% less ownership
Funds ownership: 4.12% → 3.88% (-0.23%)
3% less capital invested
Capital invested by funds: $9.44M → $9.14M (-$293K)
14% less funds holding
Funds holding: 37 → 32 (-5)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$88.9K |
| 2 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$60K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$58.9K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$19.8K |
| 5 |
RWM
Revisor Wealth Management
Akron,
Ohio
|
+$15.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$515K |
| 2 |
Renaissance Technologies
New York
|
-$86.1K |
| 3 |
Jane Street
New York
|
-$47.2K |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$37.9K |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$36.4K |
NMTC Hedge Fund Activity: Q1 2026 in Review
32 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q1 2026, worth a combined $9.14M — down 3.1% from $9.44M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of NMTC and 7 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 4 added.
The largest buyer was Geode Capital Management, adding an estimated $88.9K. The largest seller was Sio Capital Management, cutting an estimated $515K.
- 32 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q1 2026, down from 37 in Q4 2025.
- Funds reported $9.14M of NeuroOne Medical Technologies stock for Q1 2026, down 3.1% quarter-over-quarter.
- 7 funds opened new NeuroOne Medical Technologies positions in Q1 2026 and 11 closed out, a net change of -4 holders.
- The largest NeuroOne Medical Technologies buyer in Q1 2026 was Geode Capital Management, an estimated $88.9K added.
- The largest NeuroOne Medical Technologies seller in Q1 2026 was Sio Capital Management, an estimated $515K sold.
Based on aggregated 13F filings for Q1 2026.